192 related articles for article (PubMed ID: 35690642)
1. Phenazine derivatives attenuate the stemness of breast cancer cells through triggering ferroptosis.
Yang Y; Lu Y; Zhang C; Guo Q; Zhang W; Wang T; Xia Z; Liu J; Cheng X; Xi T; Jiang F; Zheng L
Cell Mol Life Sci; 2022 Jun; 79(7):360. PubMed ID: 35690642
[TBL] [Abstract][Full Text] [Related]
2. HET0016 attenuates the stemness of breast cancer cells through targeting CYP4Z1.
Liu H; Qin H; Zhou Y; Yuan Y; Liu Y; Chen Y; Yang Y; Ni H; Xi T; Zheng L
Mol Carcinog; 2021 Jun; 60(6):413-426. PubMed ID: 33866606
[TBL] [Abstract][Full Text] [Related]
3. Dichloroacetate attenuates the stemness of colorectal cancer cells via trigerring ferroptosis through sequestering iron in lysosomes.
Sun J; Cheng X; Pan S; Wang L; Dou W; Liu J; Shi X
Environ Toxicol; 2021 Apr; 36(4):520-529. PubMed ID: 33166055
[TBL] [Abstract][Full Text] [Related]
4. MiR-375 reduces the stemness of gastric cancer cells through triggering ferroptosis.
Ni H; Qin H; Sun C; Liu Y; Ruan G; Guo Q; Xi T; Xing Y; Zheng L
Stem Cell Res Ther; 2021 Jun; 12(1):325. PubMed ID: 34090492
[TBL] [Abstract][Full Text] [Related]
5. An iron oxyhydroxide-based nanosystem sensitizes ferroptosis by a "Three-Pronged" strategy in breast cancer stem cells.
Wu K; Zhang W; Chen H; Wu J; Wang X; Yang X; Liang XJ; Zhang J; Liu D
Acta Biomater; 2023 Apr; 160():281-296. PubMed ID: 36822484
[TBL] [Abstract][Full Text] [Related]
6. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy.
Pham PV; Phan NL; Nguyen NT; Truong NH; Duong TT; Le DV; Truong KD; Phan NK
J Transl Med; 2011 Dec; 9():209. PubMed ID: 22152097
[TBL] [Abstract][Full Text] [Related]
8. Do Different Stemness Markers Identify Different Pools of Cancer Stem Cells in Malignancies: A Study on ER+ and ER-Breast Cancer Cell Lines.
Chopra S; Goel S; Thakur B; Bhatia A
Pathol Oncol Res; 2020 Jan; 26(1):371-378. PubMed ID: 30361903
[TBL] [Abstract][Full Text] [Related]
9. The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors.
Chang WW; Lin RJ; Yu J; Chang WY; Fu CH; Lai A; Yu JC; Yu AL
Breast Cancer Res; 2013 May; 15(3):R39. PubMed ID: 23663564
[TBL] [Abstract][Full Text] [Related]
10. Sinomenine hydrochloride suppresses the stemness of breast cancer stem cells by inhibiting Wnt signaling pathway through down-regulation of WNT10B.
Li X; Chen W; Huang L; Zhu M; Zhang H; Si Y; Li H; Luo Q; Yu B
Pharmacol Res; 2022 May; 179():106222. PubMed ID: 35413424
[TBL] [Abstract][Full Text] [Related]
11. WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
Xu L; Zhang L; Hu C; Liang S; Fei X; Yan N; Zhang Y; Zhang F
Int J Oncol; 2016 Mar; 48(3):1175-86. PubMed ID: 26781188
[TBL] [Abstract][Full Text] [Related]
12. mTOR inhibition suppresses salinomycin-induced ferroptosis in breast cancer stem cells by ironing out mitochondrial dysfunctions.
Cosialls E; Pacreau E; Duruel C; Ceccacci S; Elhage R; Desterke C; Roger K; Guerrera C; Ducloux R; Souquere S; Pierron G; Nemazanyy I; Kelly M; Dalmas E; Chang Y; Goffin V; Mehrpour M; Hamaï A
Cell Death Dis; 2023 Nov; 14(11):744. PubMed ID: 37968262
[TBL] [Abstract][Full Text] [Related]
13. Itraconazole attenuates the stemness of nasopharyngeal carcinoma cells via triggering ferroptosis.
Xu Y; Wang Q; Li X; Chen Y; Xu G
Environ Toxicol; 2021 Feb; 36(2):257-266. PubMed ID: 32951314
[TBL] [Abstract][Full Text] [Related]
14. β1,4-Galactosyltransferase V Modulates Breast Cancer Stem Cells through Wnt/β-catenin Signaling Pathway.
Tang W; Li M; Qi X; Li J
Cancer Res Treat; 2020 Oct; 52(4):1084-1102. PubMed ID: 32599982
[TBL] [Abstract][Full Text] [Related]
15. BRD4/nuclear PD-L1/RelB circuit is involved in the stemness of breast cancer cells.
Kim SL; Choi HS; Lee DS
Cell Commun Signal; 2023 Nov; 21(1):315. PubMed ID: 37924094
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem cell regulated phenotypic plasticity protects metastasized cancer cells from ferroptosis.
Wu M; Zhang X; Zhang W; Chiou YS; Qian W; Liu X; Zhang M; Yan H; Li S; Li T; Han X; Qian P; Liu S; Pan Y; Lobie PE; Zhu T
Nat Commun; 2022 Mar; 13(1):1371. PubMed ID: 35296660
[TBL] [Abstract][Full Text] [Related]
17. Diallyl Disulfide Inhibits Breast Cancer Stem Cell Progression and Glucose Metabolism by Targeting CD44/PKM2/AMPK Signaling.
Xie X; Huang X; Tang H; Ye F; Yang L; Guo X; Tian Z; Xie X; Peng C; Xie X
Curr Cancer Drug Targets; 2018; 18(6):592-599. PubMed ID: 29110616
[TBL] [Abstract][Full Text] [Related]
18. Enhanced SLC34A2 in breast cancer stem cell-like cells induces chemotherapeutic resistance to doxorubicin via SLC34A2-Bmi1-ABCC5 signaling.
Ge G; Zhou C; Ren Y; Tang X; Wang K; Zhang W; Niu L; Zhou Y; Yan Y; He J
Tumour Biol; 2016 Apr; 37(4):5049-62. PubMed ID: 26546432
[TBL] [Abstract][Full Text] [Related]
19. miR-638 represses the stem cell characteristics of breast cancer cells by targeting E2F2.
Lin QY; Wang JQ; Wu LL; Zheng WE; Chen PR
Breast Cancer; 2020 Jan; 27(1):147-158. PubMed ID: 31410735
[TBL] [Abstract][Full Text] [Related]
20. Erianin suppressed lung cancer stemness and chemotherapeutic sensitivity via triggering ferroptosis.
Lv J; Wang Z; Liu H
Environ Toxicol; 2024 Feb; 39(2):479-486. PubMed ID: 37209271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
